.Attribute Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for introduction of patients along with MASLD as well as dimension of liver end results in cardio-- renal-- metabolic trials, when records advise mechanistically conceivable advantages and also medical security-- and also describes factors for trial style and governing commendation.